BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 22704737)

  • 1. Multiplexing immunoassays for cytokine detection in the serum of patients with rheumatoid arthritis: lack of sensitivity and interference by rheumatoid factor.
    Churchman SM; Geiler J; Parmar R; Horner EA; Church LD; Emery P; Buch MH; McDermott MF; Ponchel F
    Clin Exp Rheumatol; 2012; 30(4):534-42. PubMed ID: 22704737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiplex cytokine analyses in patients with rheumatoid arthritis require use of agents blocking heterophilic antibody activity.
    Olsson P; Theander E; Bergström U; Jovinge S; Jacobsson L; Turesson C
    Scand J Rheumatol; 2017 Jan; 46(1):1-10. PubMed ID: 27172254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erroneous augmentation of multiplex assay measurements in patients with rheumatoid arthritis due to heterophilic binding by serum rheumatoid factor.
    Todd DJ; Knowlton N; Amato M; Frank MB; Schur PH; Izmailova ES; Roubenoff R; Shadick NA; Weinblatt ME; Centola M; Lee DM
    Arthritis Rheum; 2011 Apr; 63(4):894-903. PubMed ID: 21305505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rheumatoid factor and falsely elevated results in commercial immunoassays: data from an early arthritis cohort.
    Gehin JE; Klaasen RA; Norli ES; Warren DJ; Syversen SW; Goll GL; Bjøro T; Kvien TK; Mjaavatten MD; Bolstad N
    Rheumatol Int; 2021 Sep; 41(9):1657-1665. PubMed ID: 33944985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine measurements and possible interference from heterophilic antibodies--problems and solutions experienced with rheumatoid factor.
    Bartels EM; Ribel-Madsen S
    Methods; 2013 May; 61(1):18-22. PubMed ID: 23306035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of a commercially available multiplex platform in the assessment of circulating cytokines and chemokines in patients with rheumatoid arthritis and osteoarthritis.
    Maloley PM; England BR; Sayles HR; Thiele GM; Duryee MJ; Hunter CD; Payne JB; Mikuls TR
    J Immunol Methods; 2021 Aug; 495():113048. PubMed ID: 33933473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Species cross-reactivity of rheumatoid factors and implications for immunoassays.
    Holm BE; Sandhu N; Tronstrøm J; Lydolph M; Trier NH; Houen G
    Scand J Clin Lab Invest; 2015 Jan; 75(1):51-63. PubMed ID: 25347362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Serological Biomarkers in Rheumatoid Arthritis and Their Combination to Improve Diagnostic Performance.
    Martinez-Prat L; Nissen MJ; Lamacchia C; Bentow C; Cesana L; Roux-Lombard P; Gabay C; Mahler M
    Front Immunol; 2018; 9():1113. PubMed ID: 29928272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine detection and simultaneous assessment of rheumatoid factor interference in human serum and synovial fluid using high-sensitivity protein arrays on plasmonic gold chips.
    Valentina M; Jan F; Peder NL; Bo Z; Hongjie D; Pernille K
    BMC Biotechnol; 2015 Aug; 15():73. PubMed ID: 26268325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of different enzyme immunoassays for measurement of IgM and IgA rheumatoid factors.
    Bas S; Perneger TV; Kunzle E; Vischer TL
    Ann Rheum Dis; 2002 Jun; 61(6):505-10. PubMed ID: 12006322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.
    Schellekens GA; Visser H; de Jong BA; van den Hoogen FH; Hazes JM; Breedveld FC; van Venrooij WJ
    Arthritis Rheum; 2000 Jan; 43(1):155-63. PubMed ID: 10643712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of heterophilic antibody blocking agents in reducing false positive interference in immunoassays for IL-17AA, IL-17FF, and IL-17AF.
    DeForge LE; Loyet KM; Delarosa D; Chinn J; Zamanian F; Chuntharapai A; Lee J; Hass P; Wei N; Townsend MJ; Wang J; Wong WL
    J Immunol Methods; 2010 Oct; 362(1-2):70-81. PubMed ID: 20833179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
    Greiner A; Plischke H; Kellner H; Gruber R
    Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of Autoantibody Isotypes Increases the Sensitivity of Serodiagnostics in Rheumatoid Arthritis.
    Sieghart D; Platzer A; Studenic P; Alasti F; Grundhuber M; Swiniarski S; Horn T; Haslacher H; Blüml S; Smolen J; Steiner G
    Front Immunol; 2018; 9():876. PubMed ID: 29740454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of glucose-6-phosphate isomerase assay in early diagnosis of rheumatoid arthritis].
    Xu J; Liu J; Zhu L; Zhang XW; Li ZG
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):942-946. PubMed ID: 27987494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells.
    Mathsson L; Lampa J; Mullazehi M; Rönnelid J
    Arthritis Res Ther; 2006; 8(3):R64. PubMed ID: 16569263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of serum IgA rheumatoid factor levels with disease severity in rheumatoid arthritis.
    Päi S; Päi L; Birkenfeldt R
    Scand J Rheumatol; 1998; 27(4):252-6. PubMed ID: 9751464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance evaluation of cytometric bead assays for the measurement of lung cytokines in two rodent models.
    Young SH; Antonini JM; Roberts JR; Erdely AD; Zeidler-Erdely PC
    J Immunol Methods; 2008 Feb; 331(1-2):59-68. PubMed ID: 18089291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheumatoid factor and anti-cyclic citrullinated peptide (anti-CCP) antibodies with hepatitis B and hepatitis C infection: Review.
    Zengin O; Yıldız H; Demir ZH; Dağ MS; Aydınlı M; Onat AM; Kısacık B
    Adv Clin Exp Med; 2017 Sep; 26(6):987-990. PubMed ID: 29068601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic performance of anti-cyclic citrullinated peptide and rheumatoid factor in patients with rheumatoid arthritis.
    Chang PY; Yang CT; Cheng CH; Yu KH
    Int J Rheum Dis; 2016 Sep; 19(9):880-6. PubMed ID: 25940989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.